The duty to disclose adverse clinical trial results.
Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results...
Κύριοι συγγραφείς: | Liao, S, Sheehan, M, Clarke, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2009
|
Παρόμοια τεκμήρια
-
Disclosing clinical trial results: publicity, significance and independence.
ανά: Liao, S, κ.ά.
Έκδοση: (2009) -
Randomization should be disclosed to potential research subjects.
ανά: Binik, A, κ.ά.
Έκδοση: (2013) -
Comparative Study of Securities issuer's affirmative duty to disclose information
in Iranian and American Law
ανά: Morteza Shahidi, κ.ά.
Έκδοση: (2020-04-01) -
Press releases for Phase 2 clinical trial topline results: Have the objective pre-specified efficacy results been disclosed?
ανά: Zheng Su, κ.ά.
Έκδοση: (2016-12-01) -
HIV/AIDS, TO DISCLOSE OR NOT TO DISCLOSE: THAT IS THE QUESTION
ανά: Andra le Roux-Kemp
Έκδοση: (2013-04-01)